Group 1 - The core point of the article is that Suzhou Xueji Biotechnology Co., Ltd. has recently completed a B+ round of financing, raising 40 million RMB, with additional investments received within a week [1] - The company was established in 2021 and is located in Suzhou, focusing on research and experimental development [1] - The registered capital of the company is 5.986108 million RMB, and it has completed the B+ round financing by 2026 [1] Group 2 - Suzhou Xueji Biotechnology has made one external investment and holds 101 trademark registrations and 12 patents [1] - The company possesses six administrative licenses [1] - The shareholders of Suzhou Xueji Biotechnology include Zhu Fangfang, Nanjing Weidu Alpha Venture Capital Partnership, Suzhou Yueji Enterprise Management Partnership, Suzhou Ningji Enterprise Management Partnership, and Zhaoyin Growth No. 3 Investment Partnership [1]
苏州血霁生物科技有限公司获“B+轮”融资，金额4000万人民币
Sou Hu Cai Jing·2026-01-05 07:24